Stock Warrant
WARRANTApollomics Inc. Warrant
No redemption notice detected. Our weekly 8-K watcher runs every Friday and stamps this card if the issuer files a redemption 8-K.
⚠ No exercise price on file — most SPAC warrants use $11.50; check the SEC filing linked above.
APLMW is Apollomics, Inc. — a non-dividend-paying stock. Trading at $0.01. Market cap: $1M.
Stock snapshot
| Price | $0.01 |
| Market cap | $1M |
| Sector | — |
| Exchange | NCM |
| Pays dividend | No |
About APLMW
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
Frequently asked
What is APLMW's current stock price?
APLMW (Apollomics, Inc.) is currently trading at $0.01.
Does APLMW pay a dividend?
APLMW (Apollomics, Inc.) does not currently pay a regular dividend.
Track APLMW in DiviDrip
Add APLMW to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search APLMW and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-29. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.